@MyCartis to spin out #pointofneed #diagnostics business in new company ANTELOPE Dx - #startup raises 5,1 million EUR
Read full article: mycartis.net/PDF/PressReleas…
MyCartis retweeted
Here is AntelopeDx. Exciting novel POC bodyfluid #diagnostics play launches with @MyCartis twist and Eur 5M fresh money #BeHealth @ugent #STD #photonics #MedicalDevices antelope-dx.com/
PRESS RELEASE - MyCartis and XVIVO Perfusion AB engage to develop a fast #diagnostic test to assess the quality of #donated #organs before #transplantation Read the full article: mycartis.net/PDF/PressReleas…
Saving lives by making more donor organs available for successful transplantation. Read MyCartis' White Paper on this topic.
Download your copy: mycartis.net/PDF/Whitepaper_…
MyCartis to engage in point-of-need testing with the ANTELOPE Dx technology: Clinical lab performance with the ease-of-use of a pregnancy test mycartis.net/PDF/Press%20rel…
#diagnostics #pointofcare #MyCartis #AntelopeDx #Evalution #Infectiousdiseases #antibioticresistance #photonics
Visit @MyCartis at #Kfg2018 organized by @flandersbio booth 67. MyCartis' #EVALUTION® leverages high quality analytical performance from conventional #immunodiagnostic approaches with the unique capability to quantify and monitor binding reactions in real-time.
MyCartis' #EVALUTION® leverages high quality analytical performance from conventional #immunodiagnostic approaches with the unique capability to quantify and monitor binding reactions in real-time. Visit our new website mycartis.net
@MyCartis has moved to its new office! You can reach us via our new phone number +32 9 2779 888 and we are located at Industriezone Zwijnaarde 7C, B-9052 Zwijnaarde, Belgium, in the new Bioscape buildings (svr-architects.eu/project/bi…)
@MyCartis @medica2017 HALL 3 / booth J74 - optimized binding kinetics and binding reactions can be followed in real-time - #DMAT® provides the perfect platform to assess binding interactions and hence the potency and avidity of the #protein-#antibody interaction. #diagnostics
#MyCartis appointed Philippe Stas as CEO & Hilde Windels as Executive Chair mycartis.net/825/ #evalution #immunology #diagnostics
#MyCartis @VIBLifeSciences: Immune response monitoring with real-time multiplex #antibody analysis. Read mycartis.net/?p=292 #immunology
J. She, Sc.&Tech.Dir. #MyCartis, paper with #NMI. Performance of Multiplex Serological Assay on #Evalution (r) Read: mdpi.com/2227-7382/5/4/24/pd…
Spin-off van Biocartis haalt 10 miljoen euro op tijd.be/r/t/1/id/9921159?upd… via @tijd
MyCartis retweeted
FREE Access to our paper on #multiplex #microfluidic #influenza detection using @MyCartis Evalution at ow.ly/7pG730e2gDH
Visit #MyCartis at #KFG2017 (booth #29): discover #Evalution™, real-time kinetic read-outs on complex clinical samples! (RUO)
1
MyCartis retweeted
Great talk by Wouter Laroy on personalized medicine and our Evalution technology at the Biotechnica in Hannover.
Tomorrow 7/10 11.30 HRS @WouterLaroy on stage #BIOTECHNICA talking about next generation Biomarker tools and personalized medicine.
1
Want to see a multiplexing technology delivering an ImmunoAssay in <2 hours
Come to #BIOTECHNICA stand A59 @MyCartis
1
MyCartis retweeted
Joseph She from Mycartis at #NGAPA15: Evaluation multiplex Immunoassay platform: fast, easy, sensitive detection of DNA/proteins
Dr Joseph She will be presenting at #NGAPA15 on June 15: EVALUTION: The new multiplexing solution for your biomarkers vibconferences.be/event/next…

















